custom masters papers custom wrting writing the literature review completing your qualitative dissertation bloomberg volpe research paper thesis statement generator phd research proposal chemistry how to write a really good college application essay
Skip to main content

Optical Tomographic Device for Combination with MR/CT/PET/SPECT in Preclinical Imaging

Ref-Nr: TA-P-706


DKFZ developed an optical imaging detector (25 mm x 100 mm photon sensor) for fluorescence and bioluminescence in small animal imaging, which is compatible for magnetic resonance imaging (MRI), computer tomography (CT), positron electron tomography (PET) and Single-photon emission computed tomography (SPECT). The instrument has been evaluated regarding ist optical performance including radiation durability using various phantoms and measurement setups and was successfully used in a number of preclinical studies such as simultaneous positron (18F-FDG, 68Ga-RGD) - bioluminescence (PC-3-hVEGF-Luc) imaging of reporter gene expression and receptor targeting in mice or simultaneous imaging of fluorescent XenoLight-RediJect-2-DG-750 and radiolabeled FDG probes.


Optical techniques, such as bioluminescence and fluorescence, are emerging as powerful new modalities for molecular imaging in disease and therapy. Combining innovative molecular biology and chemistry, researchers have developed optical methods for imaging a variety of cellular and molecular processes in vivo, including protein interactions, protein degradation, and protease activity. Whereas optical imaging has been used primarily for research in small-animal models, there are several areas in which optical molecular imaging will translate to clinical medicine.

Planar optical imaging and optical tomography (OT) are emerging as alternative molecular imaging modalities that detect light propagated through tissue at single or multiple projections. A number of optical-based imaging techniques are available, from macroscopic fluorescence reflectance imaging to fluorescence imaging/tomography that has recently been demonstrated to localize and quantify fluorescent probes in deep tissues at high sensitivities at millimeter resolutions.

The instrument has been evaluated regarding its optical performance, including radiation durability, using various phantoms and measurement setups, and was successfully used in a number of preclinical studies, such as simultaneous positron (18FFDG, 68Ga-RGD) - bioluminescence (PC-3- hVEGF-Luc) imaging of reporter gene expression and receptor targeting in mice or simultaneous imaging of fluorescent XenoLight-RediJect-2-DG750 and radio-labeled FDG probes. 

Bilder & Videos


Compatibility of light detection with PET has been accomplished by the development of an optical detector that consists of a 25 mm x 100 mm photon sensor (liquid cooled) for light detection, a microlens array for field-of-view definition, a septum mask for cross-talk suppression, and a transferable filter for wavelength selection. A single detector possesses an effective thickness of less than 8 mm and is operated at close proximity to the imaged object. Multiple detectors are arranged so as to form a hexagonal detector geometry allowing circumferential data acquisition through 360°. Adjacent to each detector, optical components for single spot and total object light illumination are integrated to facilitate fluorescence imaging and tomography. The outer diameter of the overall light-tight cylinder housing is 118 mm. All materials of the instrument have been selected for low attenuation and scattering of high-energy (isotopic) photons. Hence, this system is fully insertable into any PET system with a minimum bore diameter of 120 mm. Acquired optical sensor data are back-projected onto the animal's surface via an inverse mapping algorithm to form projection surface images. FMT data reconstruction is guided by priors from the reconstructed PET data. 


  • No necessity for contact between detector and object
  • Thin CMOS detector (option for small device)
  • High resolution/sensitivity
  • Combination MR/CT/PET/SPECT possible

Deutsches Krebsforschungszentrum DKFZ

Dr. Frieder Kern
Im Neuenheimer Feld 280
69120 Heidelberg





Angebot Anbieter-Website

Kontakt | Geschäftsstelle

TransferAllianz e. V.
Christiane Bach-Kaienburg

c/o TransMIT GmbH
Kerkrader Straße 3
D-35394 Gießen